单侧耳聋人工耳蜗植入者使用CIQOL-35的听力学与患者报告结局
回顾性病例复习纳入17例单侧耳聋人工耳蜗植入患者,比较术前与术后AzBio言语感知及CIQOL-35生活质量评分,并与非单侧耳聋植入者比较。术后植入耳AzBio安静环境评分中位数从3%升至76%,多个CIQOL-35子领域评分改善,多数子领域达到或超过非单侧耳聋组。
要点
- 单侧耳聋植入耳AzBio安静环境评分中位数由术前3%升至术后76%(p < .01)。
- CIQOL-35的娱乐、聆听努力、社交和全局子领域评分术后显著改善(p < .05)。
- 单侧耳聋患者术后多数子领域CIQOL-35评分等于或高于非单侧耳聋植入者。
核心结论
- 单侧耳聋人工耳蜗植入患者不仅植入耳言语感知测试显著改善,CIQOL-35多个生活质量子领域也改善,该量表是唯一经过验证的人工耳蜗生活质量工具。
研究设计与样本
- 回顾性病例复习,设置于三级大学医院系统。
- 纳入17例单侧人工耳蜗且对侧未助听纯音平均听阈≤30 dB的单侧耳聋患者,中位年龄60.2岁(四分位距50.9-64.9岁),7/17(41%)为女性。
- 比较术前与术后AzBio表现及CIQOL-35 Profile评分,并将术后指标与无单侧耳聋的CI患者比较。
主要发现
- 中位每日使用时间8.2小时(四分位距5.4-11.9小时),中位随访12.0个月。
- 拟植入耳术前AzBio安静环境中位评分3%(四分位距0%-6%),术后中位评分76%(四分位距47%-86%)(p < .01)。
- CIQOL-35子领域中位评分术前 vs 术后:娱乐17 vs 21,聆听努力12 vs 14,社交17 vs 22,全局28 vs 35(p < .05)。
- 与年龄匹配的非单侧耳聋CI组(单侧植入N = 19,序贯植入N = 6)相比,单侧耳聋患者术后多数子领域(6/7)CIQOL-35评分等于或更高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Describe the effect that cochlear implantation (CI) has on audiometric outcomes and quality of life (QOL) in patients with single-sided deafness (SSD). STUDY DESIGN: Retrospective case review. SETTING: Tertiary university hospital system. METHODS: Preoperative and postoperative AzBio performance and Cochlear Implant Quality of Life-35 (CIQOL-35) Profile scores in CI patients with SSD were compared, and postoperative measures were compared to those from CI patients without SSD. RESULTS: Seventeen patients with unilateral CI and contralateral unaided pure-tone averages ≤30 dB were included. The median age was 60.2 (interquartile range [IQR], 50.9-64.9 years), and 7/17 (41%) were women. Median daily use was 8.2 hour (IQR, 5.4-11.9 h). The median preoperative AzBio quiet score in the ear to be implanted was 3% (IQR, 0%-6%). After a median follow-up of 12.0 months, the median postoperative AzBio quiet score was 76% (IQR, 47%-86%) (p < .01). SSD subjects demonstrated statistically significant improvements in median scores on the following CIQOL-35 subdomains following implantation: Entertainment (17 preoperatively vs 21 postoperatively), Listening Effort (12 vs 14), Social (17 vs 22), and Global (28 vs 35; p < .05). SSD patients achieved equal or higher postoperative CIQOL-35 scores in most subdomains (6/7) compared to an age-matched group of non-SSD CI recipients who underwent unilaterally (N = 19) or sequential (N = 6) implantation. CONCLUSION: SSD CI patients not only demonstrate significant improvements in speech perception testing in the implanted ear but also exhibit improvement in multiple QOL subdomains on the CIQOL-35, the only validated cochlear implant QOL instrument.
引用
- Mitton TJ, Yancey KL, Isaacson B, et al. Audiometric and Patient-Reported Outcomes in Single-Sided Deafness Cochlear Implant Recipients Using the CIQOL-35. Otolaryngol Head Neck Surg. 2023. PMID: 36871181. doi:10.1002/ohn.162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。